MACKAY MEMORIAL HOSPITAL

The 2024 Taiwan Healthcare+ Expo showcased six transformative cancer treatments: AI diagnostics, immunotherapy, precision testing, targeted therapy, radiotherapy, and innovative therapies. These advancements promise more effective, personalized, and less invasive cancer care.

Combining Astragalus Polysaccharides (PG2) with standard chemoradiotherapy (CCRT) significantly improves survival rates for advanced esophageal cancer patients, according to a study by PhytoHealth Corporation. The study found that PG2, a proprietary extract of Astragalus membranaceus roots, enhances immune system modulation and tumor suppression, offering new hope for esophageal cancer treatment.